Efficacy of Type 2 PRRSV vaccine against challenge with the Chinese lineage 1 (NADC30-like) PRRSVs in pigs

[1]  M. Luo,et al.  Emergence of a novel highly pathogenic porcine reproductive and respiratory syndrome virus in China , 2017, Transboundary and emerging diseases.

[2]  Lei Xu,et al.  Efficacy evaluation of three modified-live virus vaccines against a strain of porcine reproductive and respiratory syndrome virus NADC30-like. , 2017, Veterinary microbiology.

[3]  Y. Xiaoyan,et al.  Molecular characterization of NADC30-like PRRSV isolate FJLY01 from Fujian. , 2017 .

[4]  P. Jiang,et al.  Pathogenicity and antigenicity of a novel NADC30-like strain of porcine reproductive and respiratory syndrome virus emerged in China. , 2016, Veterinary microbiology.

[5]  Yingying Li,et al.  Commercial vaccines provide limited protection to NADC30-like PRRSV infection. , 2016, Vaccine.

[6]  Shen Yang,et al.  Characterization of three porcine reproductive and respiratory syndrome virus isolates from a single swine farm bearing strong homology to a vaccine strain. , 2015, Veterinary microbiology.

[7]  M. Shi,et al.  Importation and Recombination Are Responsible for the Latest Emergence of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus in China , 2015, Journal of Virology.

[8]  H. Tun,et al.  Re-emerging of porcine respiratory and reproductive syndrome virus (lineage 3) and increased pathogenicity after genomic recombination with vaccine variant. , 2015, Veterinary microbiology.

[9]  K. Lager,et al.  Efficacy of Type 2 PRRSV vaccine against Chinese and Vietnamese HP-PRRSV challenge in pigs. , 2014, Vaccine.

[10]  S. Napthine,et al.  Transactivation of programmed ribosomal frameshifting by a viral protein , 2014, Proceedings of the National Academy of Sciences.

[11]  F. Blecha,et al.  Comparison of Host Immune Responses to Homologous and Heterologous Type II Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Challenge in Vaccinated and Unvaccinated Pigs , 2014, BioMed research international.

[12]  C. S. Kristensen,et al.  Genetic and antigenic characterization of complete genomes of Type 1 Porcine Reproductive and Respiratory Syndrome viruses (PRRSV) isolated in Denmark over a period of 10 years. , 2013, Virus research.

[13]  Koichiro Tamura,et al.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.

[14]  G. Castro,et al.  Molecular analysis of Porcine Circovirus Type 2 strains from Uruguay: evidence for natural occurring recombination. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[15]  Zuzhang Wei,et al.  Immunization of pigs with a type 2 modified live PRRSV vaccine prevents the development of a deadly long lasting hyperpyrexia in a challenge study with highly pathogenic PRRSV JX143. , 2013, Vaccine.

[16]  C. Chae,et al.  Comparison of the virulence of European and North American genotypes of porcine reproductive and respiratory syndrome virus in experimentally infected pigs. , 2013, Veterinary journal.

[17]  G. Tong,et al.  Highly pathogenic porcine reproductive and respiratory syndrome virus GP5 B antigenic region is not a neutralizing antigenic region. , 2012, Veterinary microbiology.

[18]  J. F. Atkins,et al.  Efficient −2 frameshifting by mammalian ribosomes to synthesize an additional arterivirus protein , 2012, Proceedings of the National Academy of Sciences.

[19]  T. Nicholson,et al.  Genomic sequence and virulence comparison of four Type 2 porcine reproductive and respiratory syndrome virus strains. , 2012, Virus research.

[20]  I. Díaz,et al.  Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine. , 2012, Veterinary journal.

[21]  M. Murtaugh,et al.  Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS). , 2011, Vaccine.

[22]  J. F. Atkins,et al.  Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production , 2011, The Journal of general virology.

[23]  Vincent Moulton,et al.  RDP3: a flexible and fast computer program for analyzing recombination , 2010, Bioinform..

[24]  E. Snijder,et al.  The PRRSV replicase: Exploring the multifunctionality of an intriguing set of nonstructural proteins , 2010, Virus Research.

[25]  Jun Li,et al.  Phylogeny-Based Evolutionary, Demographical, and Geographical Dissection of North American Type 2 Porcine Reproductive and Respiratory Syndrome Viruses , 2010, Journal of Virology.

[26]  T. Kimman,et al.  Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. , 2009, Vaccine.

[27]  Di Liu,et al.  Emergence of Fatal PRRSV Variants: Unparalleled Outbreaks of Atypical PRRS in China and Molecular Dissection of the Unique Hallmark , 2007, PloS one.

[28]  F. Osorio,et al.  Protection against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection through Passive Transfer of PRRSV-Neutralizing Antibodies Is Dose Dependent , 2007, Clinical and Vaccine Immunology.

[29]  David Posada,et al.  Automated phylogenetic detection of recombination using a genetic algorithm. , 2006, Molecular biology and evolution.

[30]  R. Rowland,et al.  The 2b protein as a minor structural component of PRRSV☆ , 2005, Virus Research.

[31]  K. Lager,et al.  Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome. , 2003, Veterinary microbiology.

[32]  F. Osorio,et al.  Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. , 2002, Virology.

[33]  X. Meng,et al.  Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development , 2000, Veterinary Microbiology.

[34]  J. J. Meulenberg.  PRRSV, the virus. , 2000, Veterinary research.

[35]  K. Lole,et al.  Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination , 1999, Journal of Virology.

[36]  H. Nauwynck,et al.  Efficacy of an American and a European serotype PRRSV vaccine after challenge with American and European wild-type strains of the virus. , 1999 .

[37]  S. Demaret,et al.  Effect on viraemia of an American and a European serotype PRRSV vaccine after challenge with European wild-type strains of the virus , 1998, Veterinary Record.

[38]  P. Halbur,et al.  Comparative Pathogenicity of Nine US Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Isolates in a Five-Week-Old Cesarean-Derived, Colostrum-Deprived Pig Model , 1996, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[39]  P. Halbur,et al.  Comparison of the Pathogenicity of Two US Porcine Reproductive and Respiratory Syndrome Virus Isolates with that of the Lelystad Virus , 1995, Veterinary pathology.

[40]  G. Wensvoort.  Lelystad virus and the porcine epidemic abortion and respiratory syndrome. , 1993, Veterinary research.

[41]  F. Wagenaar,et al.  Lelystad virus, the cause of porcine epidemic abortion and respiratory syndrome: a review of mystery swine disease research at Lelystad. , 1992, Veterinary microbiology.

[42]  S. Goyal,et al.  Characterization of Swine Infertility and Respiratory Syndrome (SIRS) Virus (Isolate ATCC VR-2332) , 1992, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[43]  J. Grainger.  The Virus , 1940, Nature.

[44]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .